CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
37.46
1.68%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Thu: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

10X Genomics Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 36.84
Open* 37.02
1-Year Change* -25.54%
Day's Range* 37.02 - 38.29
52 wk Range 33.79-63.57
Average Volume (10 days) 1.88M
Average Volume (3 months) 23.78M
Market Cap 4.97B
P/E Ratio -100.00K
Shares Outstanding 118.21M
Revenue 590.98M
EPS -1.91
Dividend (Yield %) N/A
Beta 1.94
Next Earnings Date Feb 13, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 37.46 0.51 1.38% 36.95 38.41 36.90
Mar 27, 2024 36.84 0.34 0.93% 36.50 36.86 35.95
Mar 26, 2024 36.18 -0.43 -1.17% 36.61 36.66 36.00
Mar 25, 2024 36.26 0.15 0.42% 36.11 36.47 35.32
Mar 22, 2024 36.22 -1.58 -4.18% 37.80 37.80 36.11
Mar 21, 2024 37.93 0.19 0.50% 37.74 39.16 37.69
Mar 20, 2024 37.53 0.33 0.89% 37.20 37.83 36.20
Mar 19, 2024 37.35 1.84 5.18% 35.51 37.47 35.36
Mar 18, 2024 36.01 -0.44 -1.21% 36.45 36.73 35.78
Mar 15, 2024 36.25 -0.49 -1.33% 36.74 37.24 36.23
Mar 14, 2024 37.14 -1.01 -2.65% 38.15 38.37 36.53
Mar 13, 2024 38.46 -0.16 -0.41% 38.62 39.68 38.19
Mar 12, 2024 39.09 -1.01 -2.52% 40.10 40.20 38.68
Mar 11, 2024 40.28 0.77 1.95% 39.51 40.71 39.48
Mar 8, 2024 39.72 -1.44 -3.50% 41.16 42.79 39.45
Mar 7, 2024 40.88 -0.40 -0.97% 41.28 42.20 40.77
Mar 6, 2024 41.23 -2.29 -5.26% 43.52 43.92 41.20
Mar 5, 2024 43.38 -0.52 -1.18% 43.90 44.35 43.07
Mar 4, 2024 44.71 -0.57 -1.26% 45.28 45.30 43.38
Mar 1, 2024 45.50 -1.01 -2.17% 46.51 46.78 45.18

10x Genomics, Inc. Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 10X Genomics Inc Earnings Release
Q1 2024 10X Genomics Inc Earnings Release

Forecast

-

Previous

-
Thursday, June 13, 2024

Time (UTC)

20:30

Country

US

Event

10X Genomics Inc Annual Shareholders Meeting
10X Genomics Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 516.409 490.49 298.845 245.893 146.313
Revenue 516.409 490.49 298.845 245.893 146.313
Cost of Revenue, Total 120.386 74.091 58.468 61.033 28.661
Gross Profit 396.023 416.399 240.377 184.86 117.652
Total Operating Expense 684.353 542.743 834.508 276.466 257.077
Selling/General/Admin. Expenses, Total 298.3 257.56 199.726 130.834 87.936
Research & Development 265.667 211.752 570.923 83.097 109.9
Other Operating Expenses, Total 0 -0.66 1.27 1.502 30.58
Operating Income -167.944 -52.253 -535.663 -30.573 -110.764
Interest Income (Expense), Net Non-Operating 6.171 -0.66 -0.15 -0.274 -1.385
Other, Net -0.198 -0.802 1.337 -0.186 -0.249
Net Income Before Taxes -161.971 -53.715 -534.476 -31.033 -112.398
Net Income After Taxes -166 -58.223 -542.731 -31.251 -112.485
Net Income Before Extra. Items -166 -58.223 -542.731 -31.251 -112.485
Total Extraordinary Items
Net Income -166 -58.223 -542.731 -31.251 -112.485
Income Available to Common Excl. Extra. Items -166 -58.223 -542.731 -31.251 -112.485
Income Available to Common Incl. Extra. Items -166 -58.223 -542.731 -31.251 -112.485
Diluted Net Income -166 -58.223 -542.731 -31.251 -112.485
Diluted Weighted Average Shares 113.859 110.348 101.152 96.2416 93.8497
Diluted EPS Excluding Extraordinary Items -1.45795 -0.52763 -5.36552 -0.32471 -1.19857
Diluted Normalized EPS -1.45795 -0.52763 -5.33904 -0.32471 -1.19857
Unusual Expense (Income) 0 0 4.121
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 146.819 134.285 156.232 131.072 114.609
Revenue 146.819 134.285 156.232 131.072 114.609
Cost of Revenue, Total 47.207 35.895 36.827 30.377 27.704
Gross Profit 99.612 98.39 119.405 100.695 86.905
Total Operating Expense 210.177 186.273 179.328 171.068 177.726
Selling/General/Admin. Expenses, Total 91.51 83.28 78.887 73.401 79.337
Research & Development 71.46 67.098 63.614 67.29 70.685
Unusual Expense (Income) 0
Other Operating Expenses, Total 0 0
Operating Income -63.358 -51.988 -23.096 -39.996 -63.117
Interest Income (Expense), Net Non-Operating 4.095 3.85 2.69 1.911 1.129
Other, Net -1.504 -1.516 3.995 -1.95 -1.843
Net Income Before Taxes -60.767 -49.654 -16.411 -40.035 -63.831
Net Income After Taxes -62.414 -50.747 -17.215 -41.914 -64.458
Net Income Before Extra. Items -62.414 -50.747 -17.215 -41.914 -64.458
Net Income -62.414 -50.747 -17.215 -41.914 -64.458
Income Available to Common Excl. Extra. Items -62.414 -50.747 -17.215 -41.914 -64.458
Income Available to Common Incl. Extra. Items -62.414 -50.747 -17.215 -41.914 -64.458
Diluted Net Income -62.414 -50.747 -17.215 -41.914 -64.458
Diluted Weighted Average Shares 116.708 115.62 114.767 114.112 113.575
Diluted EPS Excluding Extraordinary Items -0.53479 -0.43891 -0.15 -0.3673 -0.56754
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.53479 -0.43891 -0.15 -0.3673 -0.56754
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 635.035 747.591 774.366 480.84 106.236
Cash and Short Term Investments 429.984 587.447 663.603 424.166 65.08
Cash & Equivalents 219.746 587.447 663.603 424.166 65.08
Total Receivables, Net 104.211 85.254 51.208 33.371 29.566
Accounts Receivable - Trade, Net 104.211 85.254 51.208 33.371 28.088
Total Inventory 81.629 59.966 29.959 15.27 8.57
Prepaid Expenses 16.578 13.896 13.029 8.033 3.02
Total Assets 1028.98 1018.83 929.341 605.923 124.31
Property/Plant/Equipment, Total - Net 359.21 230.41 119.823 48.821 11.127
Property/Plant/Equipment, Total - Gross 428.04 279.431 150.325 67.876 25.21
Accumulated Depreciation, Total -68.83 -49.021 -30.502 -19.055 -14.083
Other Long Term Assets, Total 7.366 10.917 12.798 76.262 6.947
Total Current Liabilities 130.957 110.357 118.126 63.049 32.362
Accounts Payable 21.599 17.351 4.709 13.028 8.792
Accrued Expenses 87.682 75.821 92.326 30.035 12.118
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 9.882 4.187
Other Current Liabilities, Total 21.676 17.185 21.091 10.104 7.265
Total Liabilities 223.237 201.258 190.269 185.84 101.053
Total Long Term Debt 0 0 0 19.837 25.489
Long Term Debt 0 19.837 25.489
Other Liabilities, Total 92.28 90.901 72.143 102.954 43.202
Total Equity 805.743 817.568 739.072 420.083 23.257
Redeemable Preferred Stock 0 243.244
Common Stock 0.002 0.002 0.002 0.002 0.001
Additional Paid-In Capital 1839.4 1680.86 1544.22 682.494 11.165
Retained Earnings (Accumulated Deficit) -1029.32 -863.321 -805.098 -262.367 -231.116
Other Equity, Total -4.335 0.022 -0.05 -0.046 -0.037
Total Liabilities & Shareholders’ Equity 1028.98 1018.83 929.341 605.923 124.31
Total Common Shares Outstanding 115.195 112.515 108.486 96.2416 93.8497
Other Current Assets, Total 2.633 1.028 16.567
Intangibles, Net 22.858 25.397 22.354
Goodwill, Net 4.511 4.511
Short Term Investments 210.238
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 562.348 582.94 601.894 635.035 629.422
Cash and Short Term Investments 356.907 391.385 418.29 429.984 452.386
Cash & Equivalents 311.264 325.879 332.32 219.746 233.951
Total Receivables, Net 103.847 87.685 77.94 104.211 83.549
Accounts Receivable - Trade, Net 103.847 87.685 77.94 104.211 83.549
Total Inventory 80.917 83.687 82.307 81.629 78.629
Prepaid Expenses 20.177 18.683 20.857 16.578 14.35
Other Current Assets, Total 0.5 1.5 2.5 2.633 0.508
Total Assets 948.54 989.638 1014.03 1028.98 996.207
Property/Plant/Equipment, Total - Net 354.2 355.962 366.844 359.21 328.789
Property/Plant/Equipment, Total - Gross 448.073 441.49
Accumulated Depreciation, Total -93.873 -85.528
Goodwill, Net 4.511 4.511 4.511 4.511 4.511
Intangibles, Net 21.833 22.29 22.948 22.858 23.493
Other Long Term Assets, Total 5.648 23.935 17.833 7.366 9.992
Total Current Liabilities 104.717 98.087 112.006 130.957 126.855
Accounts Payable 18.836 23.124 29.317 21.599 21.594
Accrued Expenses 59.815 56.157 63.398 87.682 85.251
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 26.066 18.806 19.291 21.676 20.01
Total Liabilities 203.324 196.337 211.645 223.237 220.415
Total Long Term Debt 0 0 0 0 0
Long Term Debt
Other Liabilities, Total 98.607 98.25 99.639 92.28 93.56
Total Equity 745.216 793.301 802.385 805.743 775.792
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 1981.36 1936.75 1883.93 1839.4 1793.39
Retained Earnings (Accumulated Deficit) -1235.47 -1142.48 -1080.07 -1029.32 -1012.11
Other Equity, Total -0.677 -0.969 -1.479 -4.335 -5.492
Total Liabilities & Shareholders’ Equity 948.54 989.638 1014.03 1028.98 996.207
Total Common Shares Outstanding 118.198 117.323 116.173 115.195 114.428
Short Term Investments 45.643 65.506 85.97 210.238 218.435
Redeemable Preferred Stock 0 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -166 -58.223 -542.731 -31.251 -112.485
Cash From Operating Activities -33.606 -21.373 -217.898 34.627 -76.409
Cash From Operating Activities 25.368 21.118 14.012 7.066 3.905
Non-Cash Items 146.443 103.177 361.202 14.048 4.156
Cash Taxes Paid 3.925 8.66 0.28 -0.022 -0.006
Cash Interest Paid 0.841 1.222 1.67 2.25 1.824
Changes in Working Capital -39.417 -87.445 -50.381 44.764 28.015
Cash From Investing Activities -350.887 -106.729 -38.394 -42.767 -6.709
Capital Expenditures -131.661 -101.278 -38.394 -42.767 -6.709
Cash From Financing Activities 15.817 35.297 468.906 414.59 105.367
Financing Cash Flow Items -5.409 -5.028 -5.848 0
Issuance (Retirement) of Stock, Net 21.226 40.325 506.01 414.59 86.628
Issuance (Retirement) of Debt, Net 0 0 -31.256 0 18.739
Foreign Exchange Effects -0.044 0.234 -0.463 -0.045 -0.018
Net Change in Cash -368.72 -92.571 212.151 406.405 22.231
Other Investing Cash Flow Items, Total -219.226 -5.451
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -50.747 -166 -148.785 -106.871 -42.413
Cash From Operating Activities -4.125 -33.606 -47.329 -37.765 -20.802
Cash From Operating Activities 6.482 25.368 18.847 12.691 6.191
Non-Cash Items 46.1 146.443 102.681 66.548 28.014
Cash Taxes Paid 2.547 3.925 3.649 3.319 2.9
Cash Interest Paid 0.436 0.841 0.841 0.841 0.841
Changes in Working Capital -5.96 -39.417 -20.072 -10.133 -12.594
Cash From Investing Activities 119.956 -350.887 -317.715 -285.085 -257.558
Capital Expenditures -5.282 -131.661 -91.927 -55.355 -28.136
Other Investing Cash Flow Items, Total 125.238 -219.226 -225.788 -229.73 -229.422
Cash From Financing Activities -3.414 15.817 10.816 8.777 2.417
Financing Cash Flow Items -5.814 -5.409 -5.409 -5.409 -5.409
Issuance (Retirement) of Stock, Net 2.4 21.226 16.225 14.186 7.826
Issuance (Retirement) of Debt, Net 0
Foreign Exchange Effects 0.024 -0.044 -0.295 -0.21 -0.018
Net Change in Cash 112.441 -368.72 -354.523 -314.283 -275.961

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

10x Genomics, Inc. Company profile

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Industry: Laboratory Diagnostic & Testing Substances

6230 Stoneridge Mall Road
PLEASANTON
CALIFORNIA 94588
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

BTC/USD

69,672.85 Price
-1.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,508.94 Price
-0.870% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading